Verizon EVP Malady reports large equity award

Verizon Communications executive Kyle Malady reported equity award activity involving Verizon common stock.

Rhea-AI Filing Summary

Verizon Communications executive Kyle Malady reported equity award activity involving Verizon common stock. On February 11, 2026, he acquired 119,409 shares of common stock at no cost through the vesting of Performance Stock Units that were tied to performance criteria other than Verizon's stock price. On the same date, 58,030 shares were disposed of at $48.97 per share to satisfy tax withholding obligations. After these transactions, Malady directly owned 61,387 shares of Verizon common stock, and indirectly held 19,608 shares through a 401(k) plan.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Malady Kyle

Role EVP and Group CEO-VZ Business

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	119,409	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	58,030	$48.97	$2.84M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 61,387 shares (Direct); Common Stock — 19,608 shares (Indirect, By 401(k))

Footnotes (1)

1. F1. These shares of common stock were issued upon the vesting of outstanding Performance Stock Units that were subject to performance criteria other than the issuer's stock price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Verizon (VZ) executive Kyle Malady report?

Kyle Malady reported an equity award vesting and related tax withholding. He acquired 119,409 Verizon common shares through Performance Stock Units and disposed of 58,030 shares at $48.97 per share to cover tax obligations, all dated February 11, 2026.

How many Verizon (VZ) shares does Kyle Malady own after this Form 4?

After the reported transactions, Kyle Malady directly owns 61,387 Verizon common shares. In addition, he indirectly holds 19,608 Verizon shares through a 401(k) plan, reflecting his total reported beneficial ownership position following the February 11, 2026 equity award activity.

Was Kyle Malady’s Verizon (VZ) share acquisition an open-market purchase?

The acquisition was not an open-market purchase. Malady received 119,409 Verizon shares at no cost upon vesting of Performance Stock Units that were tied to performance criteria other than stock price, according to the explanatory footnote in the Form 4 filing.

Why were 58,030 Verizon (VZ) shares disposed of in Kyle Malady’s Form 4?

The 58,030 Verizon shares were disposed of to satisfy tax withholding. The Form 4 lists transaction code "F," which indicates payment of tax liability by delivering securities, with the shares valued at $48.97 each on February 11, 2026.

What executive role does Kyle Malady hold at Verizon (VZ)?

Kyle Malady is reported as an officer of Verizon with the title "EVP and Group CEO-VZ Business." This senior leadership position is disclosed in the Form 4, which also confirms he is not a director or 10% beneficial owner of the company.

How were Kyle Malady’s Performance Stock Units at Verizon (VZ) structured?

The vested Performance Stock Units converted into Verizon common stock based on performance criteria. The filing explains the units were subject to performance measures other than Verizon’s stock price, and upon vesting, 119,409 common shares were issued to Kyle Malady.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 12:58 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Malady Kyle

(Last) (First) (Middle)

VERIZON COMMUNICATIONS INC.

1095 AVENUE OF THE AMERICAS

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERIZON COMMUNICATIONS INC [ VZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Group CEO-VZ Business

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		A		119,409	A	(1)	119,417	D
Common Stock	02/11/2026		F		58,030	D	$48.97	61,387	D
Common Stock								19,608	I	By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares of common stock were issued upon the vesting of outstanding Performance Stock Units that were subject to performance criteria other than the issuer's stock price.

Remarks:

	Evgeniya Berezkina, Attorney-in-fact for Kyle Malady	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.